Abstract
No public abstract is available from the verified source records.
Nuttavadee Ketaroonrut, Methus Jantarapootirat, Sirinapa Traiwanatham, Pornalat Katekao, Chutintorn Sriphrapradang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
10.1007/s40265-021-01499-w · 2021
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon‐Like Peptide‐1 Analogue in a Tablet Formulation
10.1007/s13300-021-01078-y · 2021
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial
10.1001/jama.2017.14752 · 2017
Efficacy, Safety and PK of Once‐Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model‐Informed Drug Development Approach
10.1111/dom.70769 · 2026
A Study on Accuracy and Precision of Fluid Volume Measurements by Nurses, Patients and Healthy Persons in a Clinical Setting
10.1002/nop2.1173 · 2022
Novel GLP‐1‐Based Medications for Type 2 Diabetes and Obesity
10.1210/endrev/bnaf036 · 2026
Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight
10.1111/dom.70783 · 2026
No additional external references are available.
datacite
Confidence 0%